upvote
deleted
reply
He is probably itching to get to Anthropic. After all he is one of the early investors too.
reply
As what? CEO? Demis will not take up the MTS role.
reply
The labs are all very interested in bio right now. Demis is working on Isomorphic rn (Google's version of that) but I could imagine a lab tempting him away to work on their equivalent if it had stronger momentum
reply
He was a protected entity (tambram)
reply